French et al., 1986 - Google Patents
The production of more useful monoclonal antibodies I. Modifications of the basic technologyFrench et al., 1986
- Document ID
- 14153011281442678431
- Author
- French D
- Fischberg E
- Buhl S
- Scharff M
- Publication year
- Publication venue
- Immunology today
External Links
Snippet
Hybridoma technology has greatly expanded the usefulness and application of immunoassays and created the potential for in-vivo immunodiagnosis and therapy. While the basic technique has not changed appreciably, a number of modifications have been …
- 238000005516 engineering process 0 title abstract description 9
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/24—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
- C07K16/10—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses, e.g. hepatitis E virus
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/44—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material not provided for elsewhere, e.g. haptens, metals, DNA, RNA, amino acids
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/10—Cells modified by introduction of foreign genetic material Not used, see subgroups
- C12N5/12—Fused cells, e.g. hybridomas
- C12N5/16—Animal cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| French et al. | The production of more useful monoclonal antibodies I. Modifications of the basic technology | |
| Linton et al. | Primary antibody-forming cells and secondary B cells are generated from separate precursor cell subpopulations | |
| Carson et al. | Human lymphocyte hybridomas and monoclonal antibodies | |
| EREN et al. | Human monoclonal antibodies specific to hepatitis B virus generated in a human/mouse radiation chimera: the Trimera system | |
| CY1488A (en) | Process for the production of human mono-clonal antibodies | |
| JP2735947B2 (en) | Idiotype vaccination against B-cell lymphoma | |
| JPH052318B2 (en) | ||
| US4487833A (en) | Method of preparing hybridomas and of purifying immunogenic materials | |
| Karsten et al. | Direct comparison of electric field-mediated and PEG-mediated cell fusion for the generation of antibody producing hybridomas | |
| RU99101121A (en) | POLYEPEPTIDS ABLE TO FORM ANTIGEN-BINDING STRUCTURES SPECIFIC TO RES-D ANTIGENS, DNA ENCODING THEM, METHODS FOR PRODUCING AND APPLICATION | |
| HU196456B (en) | Process for producing permanent animal and human cell lines | |
| Dorfman | The optimal technological approach to the development of human hybridomas | |
| US4792601A (en) | Monoclonal antibody to mullerian inhibiting substance | |
| US6013519A (en) | Monoclonal antibodies to antigens expressed by hematopoietic facilitatory cells | |
| US5101017A (en) | Antibodies for providing protection against P. vivax malaria infection | |
| JPH03198795A (en) | Monoclonal antibody reactive with various human leukemias and specific antigen existing widely on lymph cell and use of said antibody for diagnostic and therapeutic purpose | |
| EP0028902B1 (en) | Method for the preferential formation of hybrid cells making a desired antibody | |
| WO1992015678A1 (en) | Pcr generated dicistronic dna molecules for producing antibodies | |
| Zelenetz et al. | Follicular lymphoma: a model of lymphoid tumor progression in man | |
| Klinman | The acquisition of B-cell competence and diversity | |
| Neil et al. | Immunization of SCID-Hu mice and generation of anti–hepatitis B surface antigen–specific hybridomas by electrofusion | |
| Neil et al. | Recent improvements in the production of antibody-secreting hybridoma cells | |
| WO1990000625A1 (en) | Pre-screening for depletion and enrichment of specific b-cells | |
| JP4493882B2 (en) | Antigen and monoclonal antibody that distinguishes this antigen | |
| WO1989000607A1 (en) | Preparation of human monoclonal antibodies of selected specificity and isotypes |